Paper40410550
LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision.
Hamdy NM and 7 others. Naunyn Schmiedebergs Arch Pharmacol, 2025. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision. Papers, record 40410550. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40410550
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| RNA, Long Noncoding | Major topic |
| MicroRNAs | Major topic |
| Humans | |
| Animals | |
| Gene Expression Regulation, Neoplastic | |
| Computer Simulation |
Source PubMed
References223
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26547929 | Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma. | Oncotarget | 2015 | https://conductscience.org/library/papers/26547929 | PubMed |
| 2 | 34636091 | Long noncoding RNA Gas5 induces cell apoptosis and inhibits tumor growth via activating the CHOP-dependent endoplasmic reticulum stress pathway in human hepatoblastoma HepG2 cells. | J Cell Biochem | 2022 | https://conductscience.org/library/papers/34636091 | PubMed |
| 3 | 34504432 | Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34504432 | PubMed |
| 4 | 28129650 | MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway. | Oncotarget | 2017 | https://conductscience.org/library/papers/28129650 | PubMed |
| 5 | 37101621 | Nanoconjugated long non-coding RNA MEG3 as a new therapeutic approach for Hepatocellular carcinoma. | Heliyon | 2023 | https://conductscience.org/library/papers/37101621 | PubMed |
| 6 | 31954487 | Advances in molecular classification and precision oncology in hepatocellular carcinoma. | J Hepatol | 2020 | https://conductscience.org/library/papers/31954487 | PubMed |
| 7 | 34907204 | LncRNA LINC00667 aggravates the progression of hepatocellular carcinoma by regulating androgen receptor expression as a miRNA-130a-3p sponge. | Cell Death Discov | 2021 | https://conductscience.org/library/papers/34907204 | PubMed |
| 8 | 38013127 | LINC02561 promotes metastasis in HCC via HIF1-α/NDRG1/UPF1 axis. | Gene | 2024 | https://conductscience.org/library/papers/38013127 | PubMed |
| 9 | 36596869 | Long non-coding RNAs: definitions, functions, challenges and recommendations. | Nat Rev Mol Cell Biol | 2023 | https://conductscience.org/library/papers/36596869 | PubMed |
| 10 | 39674644 | In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation. | J Genet Eng Biotechnol | 2024 | https://conductscience.org/library/papers/39674644 | PubMed |
| 11 | 22512580 | Hypoxia-inducible factor-1alpha: molecular-targeted therapy for hepatocellular carcinoma. | Mini Rev Med Chem | 2013 | https://conductscience.org/library/papers/22512580 | PubMed |
| 12 | 32854717 | Roles of METTL3 in cancer: mechanisms and therapeutic targeting. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/32854717 | PubMed |
| 13 | 32295598 | The role of long noncoding RNAs in hepatocellular carcinoma. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32295598 | PubMed |
| 14 | 36560421 | Multi-Epitope Vaccine Design against Monkeypox Virus via Reverse Vaccinology Method Exploiting Immunoinformatic and Bioinformatic Approaches. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36560421 | PubMed |
| 15 | 30632031 | The anti-tumor activity of brown seaweed oligo-fucoidan via lncRNA expression modulation in HepG2 cells. | Cytotechnology | 2019 | https://conductscience.org/library/papers/30632031 | PubMed |
| 16 | 29568237 | Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight. | Cancer Cell Int | 2018 | https://conductscience.org/library/papers/29568237 | PubMed |
| 17 | 33116873 | Regulatory Networks of LncRNA MALAT-1 in Cancer. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33116873 | PubMed |
| 18 | 32164265 | Inflammatory Mechanisms of HCC Development. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32164265 | PubMed |
| 19 | 36293412 | Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36293412 | PubMed |
| 20 | 29803923 | The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis. | Gene | 2018 | https://conductscience.org/library/papers/29803923 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42488711 | Cell-cycle reactivation and hepatocyte identity loss in hepatocellular carcinoma: Transcriptomic hallmarks and validation strategies (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42488711 | PubMed |
| 42480981 | A Potential miR-1246-5p-H3K27ac-NOL12 Regulatory Axis and Its Putative Tumour-Promoting Function in Hepatocellular Carcinoma. | IET Syst Biol | 2026 | https://conductscience.org/library/papers/42480981 | PubMed |
| 42453334 | From In Silico to Clinic: Harnessing Noncoding RNAs for Diabetes Research and Therapy, a Step toward ncRNA Precision. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42453334 | PubMed |
| 42180949 | Identification of EFNA family as new potential prognostic biomarkers correlated with immune cell infiltration in hepatocellular carcinoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42180949 | PubMed |
| 42147940 | Hepatocellular carcinoma with extensive fatty change: a case description. | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/42147940 | PubMed |
| 42041104 | RTA‑408 induces p38‑dependent apoptosis and suppresses cell viability in hepatocellular carcinoma cells. | Hepat Oncol | 2026 | https://conductscience.org/library/papers/42041104 | PubMed |
| 42002886 | Meox1 promotes hepatocellular carcinoma progression potentially via regulation of cell cycle and p21 expression. | Cell Adh Migr | 2026 | https://conductscience.org/library/papers/42002886 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40410550
GET https://conductscience.org/api/papers/v1/40410550/references?page=2